BioXcel Therapeutics, Inc, situated in New Haven, CT, is at the forefront of innovation in the pharmaceutical industry. Utilizing an AI-based approach, the company focuses on re-innovating drug development to enhance research and development efficiencies.
This cutting-edge methodology not only enables BioXcel Therapeutics to shorten development timelines but also significantly increases the probability of success in bringing novel treatments to market. Through their dedication to AI-driven drug re-innovation, the company strives to revolutionize patient care and improve healthcare outcomes.
Generated from the website content